Landec Corporation  

(Public, NASDAQ:LNDC)   Watch this stock  
Find more results for LNDC
0.00 (0.00%)
Mar 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 10.75 - 14.84
Open     -
Vol / Avg. 0.00/67,543.00
Mkt cap 382.71M
P/E 23.37
Div/yield     -
EPS 0.61
Shares 26.88M
Beta 1.25
Inst. own 91%
Apr 1, 2015
Q3 2015 Landec Corp Earnings Call - 11:00AM EDT - Add to calendar
Mar 31, 2015
Q3 2015 Landec Corp Earnings Release - 4:00PM EDT - Add to calendar
Mar 10, 2015
Landec Corp at ROTH Conference
Jan 12, 2015
Landec Corp at Sidoti & Company Emerging Growth Institutional Investor Forum
Jan 7, 2015
Q2 2015 Landec Corp Earnings Call - Webcast
Jan 6, 2015
Q2 2015 Landec Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Nov '14) 2014
Net profit margin 2.45% 4.06%
Operating margin 2.93% 4.23%
EBITD margin - 5.73%
Return on average assets 3.90% 6.40%
Return on average equity 6.23% 10.03%
Employees 531 -
CDP Score - -


3603 Haven Avenue
United States - Map
+1-650-3061650 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Landec Corporation (Landec) designs, develops, manufactures and sells polymer products for food and agricultural products, medical devices and licensed partner applications that incorporate Landec's polymer technologies. The Company is focused on health and wellness solutions and applications within the packaged food and biomaterial markets. The Company�s Apio, Inc business operates in three operating segments: Food Products Technology, Food Export and HA-based Biomaterials. Its Food Products Technology business combines its BreatheWay food packaging technology with the capabilities of a large national food supplier and value-added produce processor which sells products under the Eat Smart and GreenLine brands. The Food Export business purchases and sells whole fruit and vegetable products predominantly to Asian markets. Its Biomaterials business and is principally involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) products.

Officers and directors

Gregory S. Skinner Chief Financial Officer, Vice President - Finance and Administration
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Nicholas Tompkins Chairman of the Board of Apio, Inc., Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Molly A. Hemmeter Chief Operating Officer
Age: 46
Bio & Compensation  - Reuters
Steven P. Bitler Ph.D. Vice President - Corporate Technology
Age: 56
Bio & Compensation  - Reuters
Larry D. Hiebert Vice President, President of Lifecore Biomedical, Inc.
Age: 58
Bio & Compensation  - Reuters
Ronald Lane Midyett Vice President; President, Chief Executive Officer of Apio, Inc.
Age: 48
Bio & Compensation  - Reuters
Gary T. Steele Director
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Albert D. Bolles Ph.D. Independent Director
Age: 57
Bio & Compensation  - Reuters
Frederick Frank Independent Director
Age: 82
Bio & Compensation  - Reuters
Steven D. Goldby Independent Director
Age: 74
Bio & Compensation  - Reuters